NFJ Investment Group LLC decreased its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 11.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,611 shares of the medical research company's stock after selling 3,925 shares during the quarter. NFJ Investment Group LLC's holdings in IQVIA were worth $7,254,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Versant Capital Management Inc grew its holdings in IQVIA by 733.3% during the second quarter. Versant Capital Management Inc now owns 125 shares of the medical research company's stock worth $26,000 after purchasing an additional 110 shares during the period. Opal Wealth Advisors LLC bought a new position in IQVIA during the second quarter worth about $27,000. Capital Performance Advisors LLP bought a new position in IQVIA during the third quarter worth about $27,000. Park Place Capital Corp bought a new position in IQVIA during the third quarter worth about $28,000. Finally, Itau Unibanco Holding S.A. bought a new position in IQVIA during the second quarter worth about $29,000. Institutional investors and hedge funds own 89.62% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on IQV shares. StockNews.com cut IQVIA from a "buy" rating to a "hold" rating in a report on Thursday, November 28th. Robert W. Baird reduced their price objective on IQVIA from $256.00 to $223.00 and set a "neutral" rating for the company in a report on Friday, November 1st. The Goldman Sachs Group reduced their price objective on IQVIA from $280.00 to $250.00 and set a "buy" rating for the company in a report on Friday, November 1st. JPMorgan Chase & Co. reduced their price objective on IQVIA from $279.00 to $240.00 and set an "overweight" rating for the company in a report on Tuesday, November 5th. Finally, Barclays reduced their price objective on IQVIA from $260.00 to $255.00 and set an "overweight" rating for the company in a report on Friday, November 1st. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $256.50.
Get Our Latest Stock Report on IQV
IQVIA Price Performance
Shares of NYSE:IQV traded up $2.27 during trading on Wednesday, hitting $202.85. 543,810 shares of the company were exchanged, compared to its average volume of 1,176,587. The business's 50 day moving average is $217.11 and its 200-day moving average is $225.67. The company has a market capitalization of $36.82 billion, a P/E ratio of 26.69, a price-to-earnings-growth ratio of 2.08 and a beta of 1.49. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. IQVIA Holdings Inc. has a 1-year low of $187.62 and a 1-year high of $261.73.
IQVIA Profile
(
Free Report)
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Featured Stories
Before you consider IQVIA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IQVIA wasn't on the list.
While IQVIA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
